Soterenol

Soterenol (INNTooltip International Nonproprietary Name), also known as soterenol hydrochloride (USANTooltip United States Adopted Name; developmental code name MJ-1992) in the case of the hydrochloride salt, is a drug of the phenethylamine family described as an adrenergic, bronchodilator, and antiasthmatic which was never marketed.^[1][2][3] It is an analogue of salbutamol and acts as a β-adrenergic receptor agonist.^[3][2] The drug was first developed in 1964^[3] and was first described in the literature by 1967.^[1]

Soterenol

Clinical data
Other names	MJ-1992
Drug class	Adrenergic; Bronchodilator; Antiasthmatic; β-Adrenergic receptor agonist
Identifiers
IUPAC name N-[2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
CAS Number	13642-52-9 14816-67-2 (hydrochloride)
PubChem CID	26162
ChemSpider	24373
UNII	9364W7589B
KEGG	C11769
ChEMBL	ChEMBL30746
CompTox Dashboard (EPA)	DTXSID40864426
Chemical and physical data
Formula	C12H20N2O4S
Molar mass	288.36 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)NCC(C1=CC(=C(C=C1)O)NS(=O)(=O)C)O
InChI InChI=1S/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3 Key:HHRNQOGXBRYCHF-UHFFFAOYSA-N